A breakthrough antiviral compound has halted long COVID symptoms in mice, offering new hope for human treatments. Here’s what researchers discovered in 2025.
Currently browsing: Future
ASSURE In the News
Next-Gen COVID-19 Vaccines by INOVIO, Ocugen, Pfizer in 2025
Explore the latest COVID-19 vaccines in development by INOVIO, Ocugen, and Pfizer. Learn about new delivery platforms and what’s next in SARS-CoV-2 protection.
COVID-19 & Economy May Disrupt 2025 Summer Travel Season
Discover how COVID-19 variants and economic challenges may affect summer travel in 2025. Learn what precautions to take and how to stay healthy on the go.
How 2025 Economic Turmoil May Affect COVID-19 Worldwide
U.S. economic turmoil and shifting federal policies in 2025 may threaten COVID-19 funding, surveillance, and vaccine access. Learn what’s at stake at home and abroad.
Anti-Vaccine Sentiment Threatens Future FDA Vaccine Approvals
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
Assessing Future Pandemic Risks and Global Preparedness in 2025
An analysis of the probability of future pandemics, current preparedness levels, and the influence of globalization on disease spread as of 2025.
Could New US Tariffs Impact COVID-19 Measures?
Explore whether the new US tariffs could affect COVID-19 response and supply chains, and if lingering pandemic effects may shape tariff policies in 2025.
Novavax Delay & RFK Jr.’s Vaccine Misinformation in 2025
Explore the latest on the Novavax COVID-19 vaccine delay and RFK Jr.’s false claims about vaccine safety, with facts from experts and public health agencies.
What March 2025 COVID Funding Cuts Mean for Americans
Discover how recent March 2025 federal cuts to COVID-19 funding impact local health departments, testing access, and pandemic preparedness across the U.S.
Comprehensive Overview of Circulating COVID-19 Variants in 2025: Symptoms and Characteristics
Explore a comprehensive overview of the currently-circulating COVID-19 variants in 2025, and their symptoms and characteristics